✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Biomerieux SA

Common Name
Biomerieux
Country
France
Sector
Healthcare
Industry
Diagnostics & Research
Employees
14,147
Ticker
BIM
Exchange
EURONEXT
Description
bioMérieux S.A. is a global leader in the field of in vitro diagnostics, providing essential solutions to detect and manage infectious diseases, cardiovascular emergencies, and oncology. The company's...

Biomerieux's Financial Statements Preview

Below are the financial statements of Biomerieux, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Goodwill
730.4a
698.8a
Other intangible assets
492a
528.6a
Property, plant and equipment
1,525.4a
1,357.1a
Right-of-use assets
170.2a
148.9a
Non-current financial assets
195a
219.4a
Investments in associates
0.8a
0.8a
Other non-current assets
9.1a
7.7a
Deferred tax assets
145.9a
92.7a
Non-current assets
3,268.9a
3,054a
Inventories and work-in-progress
1,037.3a
908.5a
Trade receivables and assets related to contracts with customers
792.3a
728.6a
Other operating receivables
176a
171.7a
Current tax receivables
21.3a
29.7a
Non-operating receivables
24.5a
14.3a
Cash and cash equivalents
449.8a
352.4a
Current assets
2,501.1a
2,205.2a
Assets held for sale
0a
0a
Total assets
5,770a
5,259.2a
Shareholders’ equity and liabilities
Share capital
12a
12a
Additional paid-in capital and reserves
3,760.6a
3,382.6a
Net income for the year
432.2a
357.6a
Group equity
4,204.9a
3,752.2a
Minority interests
6.1a
0a
Equity of consolidated companies
4,211a
3,752.2a
Long-term borrowings and debt
349.2a
355.4a
Deferred tax liabilities
25.7a
11.1a
Provisions
49.2a
53.3a
Non-current liabilities
424.1a
419.7a
Short-term borrowings and debt
141.5a
163.4a
Provisions
37.3a
41.6a
Trade payables
272.4a
265.1a
Other operating payables
574.2a
495.9a
Current tax payables
35.4a
52.8a
Non-operating payables
74.1a
68.5a
Current liabilities
1,134.9a
1,087.3a
Liabilities related to assets held for sale
0a
0a
Total shareholders’ equity and liabilities
5,770a
5,259.2a
Limited Data Preview
You are viewing a limited preview of Biomerieux’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Biomerieux’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biomerieux’s data sources below and access millions more through our Disclosure Search.

a. Biomerieux's Universal Registration Document (URD) 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?